Filter
1769
Filtered Results: 1769
Text search:
drug
registration
Featured
Recommendations
139
New Publications
556
Language
Document type
No document type
1113
Studies & Reports
242
Guidelines
198
Manuals
88
Strategic & Response Plan
77
Training Material
18
Fact sheets
16
Situation Updates
9
Resource Platforms
6
Brochures
2
Countries / Regions
India
168
Kenya
63
Uganda
49
Global
47
Ethiopia
45
Tanzania
44
South Africa
42
Sierra Leone
40
Nigeria
40
Bangladesh
39
Ghana
38
Nepal
37
Malawi
34
Western and Central Europe
34
Namibia
31
Myanmar / Burma
31
Liberia
30
Rwanda
26
Africa
26
Ukraine
24
Zambia
22
Latin America and the Carribbean
21
Eastern Europe
19
Zimbabwe
17
Botswana
17
Cambodia
16
Philippines
15
South–East Asia Region
15
Lesotho
14
Asia
13
Indonesia
11
Syria
9
Congo, Democratic Republic of
8
Mozambique
7
Eswatini/ Swaziland
7
West and Central Africa
6
Russia
6
Colombia
5
East and Southern Africa
5
Brazil
5
Pakistan
5
Tajikistan
4
Timor Leste/ East Timor
4
Benin
4
Albania
4
Senegal
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Sri Lanka
4
Georgia
4
South Sudan
4
Cameroon
3
Haiti
3
Venezuela
3
Western Pacific Region
3
Argentina
3
Moldova
3
Sudan
3
Bhutan
3
Iraq
3
North Macedonia
2
Thailand
2
China
2
Chile
2
Iran
2
Laos
2
Burkina Faso
2
Afghanistan
2
Armenia
2
Jordan
2
Germany
2
Paraguay
2
North America
2
Uruguay
2
United Kingdom
2
Bolivia
2
Vietnam
2
Papua New Guinea
2
Angola
2
Libya
2
North Korea
1
Australia
1
Gambia
1
Kazakhstan
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Malaysia
1
Morocco
1
Bulgaria
1
Guinea
1
Italy
1
USA
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Greece
1
Central African Republic
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
889
Clinical Guidelines
123
Public Health
82
Key Resources
47
Women & Child Health
45
Pharmacy & Technologies
35
Capacity Building
21
Toolboxes
TB
195
HIV
172
Mental Health
80
AMR
80
Pharmacy
75
NTDs
55
COVID-19
52
NCDs
35
Caregiver
34
Malaria
33
Conflict
27
Refugee
23
Rapid Response
19
Global Health Education
17
Disability
16
Ebola & Marburg
13
Planetary Health
8
Health Financing Toolbox
8
Specific Hazards
7
Natural Hazards
7
Polio
5
Zika
4
Cholera
2
Social Ethics
2
The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of Health to strengthen CVD management in primary health care settings. The practical, step-by step modul...
This guideline provides advice in regards to applications for Marketing Authorisations for antimicrobial veterinary medicinal products (VMPs) on the data required and the methodology to be used for performing an assessment of the risk to public health from antimicrobial resistance (AMR) due to use o...
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
GUIDELINES FOR AWWs/ASHAs/ANMs/PRIs
Economic Issues, Policies and Option for Action
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
This module introduces the “Vaccinator’s Manual”, a guideline for vaccinators. The aim of the manual is to update EPI guidelines to include all the changes since the third edition of the Vaccinators Manual (2008)
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
